Translating Complex Biology into Breakthrough Medicines
Deep Signal™ platform - the Rosetta stone for deciphering the cell signaling language critical to develop novel therapies.
InterAx combines mathematical modeling of cellular processes, experimental methods, and machine learning derived from more than 15 years of fundamental research to generate high-efficacy leads for a given GPCR target.
InterAx Deep Signal™ platform enables a deep understanding of target engagement and disease impact, enabling: Novel drugs based on deeper pharmacology understanding & Improved profiles of current drugs.
InterAx is redefining drug discovery by understanding the impact of treatments on diseases before pre-clinical trials begin – an analysis traditionally inaccessible to very early programs. Focusing on GPCR small molecules, the Deep Signal™ platform deciphers complex drug biology by uncovering disease mechanisms at the cellular signaling level. This approach starts with advanced methods centered on drug chemistry and receptor structure, and then moves beyond them – into cell signaling – integrating all this information and thereby enabling unrivaled design of differentiated drug candidates with higher efficacy, enhanced safety, and lower clinical failure rates.
InterAx uses Mechanistic models to create drugs with unique therapeutic profiles
Our Pipeline
InterAx is building a pipeline of drug candidates with superior efficacy and tolerability
With Support From
